Addiction Science Made Easy (ASME)
Research Brief Catalog
Addiction Science Made Easy, currently written by Meg Brunner, MLIS (Northwest ATTC and the NIDA CTN Dissemination Library), features two research papers per month, explaining the science in clear language and putting the findings in context for addiction workforce members. One paper typically comes from NIDA’s National Drug Abuse Treatment Clinical Trials Network (CTN), the other from a SAMHSA-funded project.
Meg Brunner
Goetz M, et al. Staff perceptions of care navigators in medication for opioid use disorder treatment settings. Substance Abuse Treatment, Prevention, and Policy 2026 (in press).
Published: July 28, 2026
Meg Brunner
Rodin NM, et al. Relationship between depression on cocaine craving over time amongst patients in a trial evaluating the use of buprenorphine on cocaine use. Drug and Alcohol Dependence Reports 2026; 20: 100460.
Published: July 28, 2026
Meg Brunner
Wanga V, et al. County-level uptake of take-home methadone and adverse events among commercially insured individuals. Journal of Addiction Medicine 2026 (in press).
Published: June 27, 2026
Meg Brunner
Ward RC, et al. Characterization of patients declining to participate in opioid overdose prevention clinical research in an emergency department setting. Journal of Substance Use and Addiction Treatment 2026 (in press).
Published: June 27, 2026
Meg Brunner
Fernandes TP, et al. Assessing the clinical competence of large language models for tobacco use disorder: A multi-domain expert evaluation. Journal of Addictive Diseases 2026 (in press).
Published: May 20, 2026
Meg Brunner
Jacob S, et al. Internet gaming disorder and nonmedical prescription drug use: The moderating role of student status. International Journal of Environmental Research and Public Health 2026;23(3):386.
Published: April 22, 2026
Meg Brunner
Potter K, et al. Patient characteristics associated with successful initiation of extended-release naltrexone in the X:BOT trial. Substance Use & Misuse 2026 (in press).
Published: April 22, 2026
Meg Brunner
Bommersbach TJ, Olfson M, Rhee TG. Association of multimodal cannabis use with adverse events among adolescents and young adults. American Journal of Preventive Medicine 2026 (in press).
Published: March 16, 2026
Meg Brunner
D’Onofrio G, et al. Emergency department-initiated buprenorphine for opioid use disorder: A randomized clinical trial. JAMA 2026; (in press).
Published: March 16, 2026
Meg Brunner, MLIS
Friedmann PD, et al. Mobile telemedicine for treating chronic hepatitis C among rural people who inject drugs: A randomized clinical trial. JAMA Network Open 2026;9(1):e2555125. Free online
Published: February 20, 2026
Meg Brunner, MLIS
Kawasaki SS, et al. Barriers to buprenorphine initiation in patients using fentanyl. JAMA Network Open 2026;9(1):e2552136. Free online
Published: February 20, 2026
Meg Brunner, MLIS
Fatehi M, et al. Treatment response in a co-occurring disorders intervention for adult drug treatment court: The role of adverse childhood experiences. Community Mental Health Journal 2025 (in press).
Published: November 1, 2025
Meg Brunner, MLIS
Paschen-Wolff MM, et al. “PrEP is always on the table”: mixed methods study of provider willingness to refer/link clients to PrEP in community sexual health and drug use-related programs. Journal of HIV/AIDS & Social Services 2025 (in press).
Published: November 1, 2025
Meg Brunner, MLIS
Burlew AK, et al. An individual-level data synthesis of Clinical Trials Network studies to examine the impact of psychosocial treatments for Black people who use cocaine and/or opioids. Drug and Alcohol Dependence 2025;276:112850.
Published: October 1, 2025
Meg Brunner, MLIS
Krueger DK, et al. Burnout and job satisfaction among U.S. peer recovery support specialists: Personal resilience and satisfaction with supervisor and organizational support as mediating mechanisms. Community Mental Health Journal 2025 (in press).
Published: October 1, 2025
Meg Brunner, MLIS
Travers L, et al. User-centered design of a web application to promote naloxone carrying among supporters of adults with opioid prescriptions. Families, Systems, & Health 2025;43(2):324-341.
Published: September 1, 2025
Meg Brunner, MLIS
Jha MK, et al. Early change in depressive symptom severity with naltrexone-bupropion combination and its association with reduction in methamphetamine use in ADAPT-2 trial. J Clin Psychiatry 2025;86(3):25m15825.
Published: September 1, 2025
Meg Brunner, MLIS
Kameg B & Cline T. Mental health and substance use treatment receipt among women veterans with a substance use disorder, 2015-2019. Issues in Mental Health Nursing 2025 (in press).
Published: August 5, 2025
Meg Brunner, MLIS
O’Grady M, et al. Tailoring treatment for substance use disorders in older adults: A mixed-methods study. Innovative Aging 2025;9(6):igaf027.
Published: July 1, 2025
Meg Brunner, MLIS
Bell SG, et al. “I don’t tell anyone I have them:” Experiences with opioid stigma from the perspective of survivors living with chronic cancer-related pain and clinicians that care for them. Journal of Pain 2025;32:10541. [doi: 10.1016/j.jpain.2025.105411] Find it in the CTN Dissemination Library
Published: June 2, 2025
Meg Brunner, MLIS
Lutgen CB, et al. Assessment of primary care team-based learning sessions for opioid use disorder. American Journal on Addictions 2025 (in press). doi: 10.1111/ajad.70050
Published: June 2, 2025
Meg Brunner, MLIS
Coles C, et al. Impact of recent stimulant use on treatment outcomes amongst individuals initiating medications for opioid use disorders: Secondary analysis of a multisite randomized controlled trials. Drug and Alcohol Dependence Reports 2025;15:100330.
Published: May 1, 2025
Meg Brunner, MLIS
Oluwoye O, et al. Proof-of-concept pilot study on the integration of a contingency management model to address substance use among individuals enrolled in early intervention programs for psychosis. Early Intervention Psychiatry 2025;19(4):e70037.
Published: May 1, 2025
Meg Brunner, MLIS
Kan E, et al. Medication-based treatment among rural, primary care patients diagnosed with opioid use disorder and alcohol use disorder. Journal of Substance Use and Addiction Treatment 2024;164:209339.
Published: April 1, 2025